Vol 52, No 4 (2021)
Editorial
Published online: 2021-08-31
Scientific life is changing: virtual and real-world experience
1
Acta Haematol Pol 2021;52(4):215-216.
Abstract
Not available
Keywords: hematologyhemato-oncology
References
- Czyżewski K, Sedláček P, Štěrba J, et al. Progress and trends in pediatric hematopoietic cell transplantation in Central-East European countries. Acta Haematol Pol. 2020; 51(3): 142–150.
- Styczynski J, Tridello G, Gil L, et al. Prognostic impact of Epstein-Barr virus serostatus in patients with nonmalignant hematological disorders undergoing allogeneic hematopoietic cell transplantation: the study of Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation. Acta Haematol Pol. 2020; 51(2): 73–80.
- Jędrzejczak WW. Polish hematology: from here to the future. Acta Haematol Pol. 2021; 52(1): 2–3.
- Giebel S, Basak G, Bieniaszewska M, et al. Current status and progress of Polish hemato-oncology. Acta Haematol Pol. 2021; 52(1): 4–17.
- Snowden JA, Styczyński J, Snarski E, et al. Haematopoietic stem cell transplantation in autoimmune diseases; an update from the EBMT Autoimmune Diseases Working Party with special reference to Poland. Acta Haematol Pol. 2021; 52(4): 217–224.
- Undas A. Anticoagulant treatment of venous thromboembolism in pregnant women. Acta Haematol Pol. 2021; 52(4): 413–418.
- Grześk G. Therapeutic monitoring of direct oral anticoagulants — a 8-year observational study. Acta Haematol Pol. 2021; 52(4): 443–449.
- Musiał J. Risk assessment of recurrent venous thromboembolism. Acta Haematol Pol. 2021; 52(4): 433–438.
- Bembnista E. Implementation of CAR-T technology into clinical practice: challenge for cell bank. Acta Haematol Pol. 2021; 52(4): 263–267.
- Firczuk M. Old and new targets for immunotherapy of B cell acute lymphoblastic leukemia. Acta Haematol Pol. 2021; 52(4): 291–299.
